Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Virtual Clinical Trials Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The virtual clinical trials market has experienced substantial growth in recent years. It is projected to increase from $12.95 billion in 2025 to $14.36 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.9%. The market’s historical expansion can be ascribed to factors such as the increasing need for faster drug development, challenges faced in traditional clinical trial participation, greater technology adoption in healthcare research, regulatory backing for decentralized models, and rising patient engagement initiatives.
The virtual clinical trials market is set to experience rapid expansion in the coming years. It is projected to reach $21.58 billion by 2030, growing at a compound annual growth rate (CAGR) of 10.7%. This growth over the forecast period is driven by factors such as the increasing demand for remote healthcare solutions, the expansion of precision medicine trials, wider adoption of digital patient monitoring tools, escalating investment in digital clinical infrastructure, and continuous innovation in decentralized trial technologies. Significant trends for the forecast period include the increasing adoption of remote clinical trial participation, the growing use of wearables and connected health devices, a rising shift toward patient-centric clinical research models, greater utilization of digital platforms for clinical monitoring, and an increased focus on reducing site-based clinical dependencies.
Get A Free Sample Report With In-Depth Market Insights:
Virtual Clinical Trials Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
A growing volume of clinical trials is projected to fuel the expansion of the virtual clinical trials market in the future. These trials involve investigative studies with human subjects, aimed at assessing the safety, effectiveness, and prospective advantages of novel medical therapies, procedures, or medications. This increase in traditional clinical trials has facilitated the emergence and advancement of virtual clinical trials, which provide a more streamlined, economical, and patient-centric method for conducting research. For example, in December 2024, the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, reported that pharmaceutical industry trials initiated in the UK saw an increase for the second year in a row, moving from 411 in 2022 to 426 in 2023. Consequently, a greater quantity of clinical trials is anticipated to stimulate the development of the virtual clinical trials market throughout the forecast period.
Virtual Clinical Trials Market Segment Trends And Revenue Contributors
The virtual clinical trials market covered in this report is segmented –
1) By Design: Observational Trials, Interventional Trials, Expanded Access Trials
2) By Phases: Phase II, Phase III, Phase IV
3) By Indication: CNS, Autoimmune Or Inflammation, Cardiovascular Disease, Metabolic Or Endocrinology, Infectious Disease, Oncology, Genitourinary, Ophthalmology, Other Indications
Subsegments:
1) By Observational Trials: Prospective Cohort Studies, Retrospective Studies, Case-Control Studies
2) By Interventional Trials: Randomized Controlled Trials (RCTs), Non-Randomized Trials, Adaptive Trials
3) By Expanded Access Trials: Single-Patient Expanded Access, Multi-Patient Expanded Access, Compassionate Use Programs
Virtual Clinical Trials Market Innovation Trends Shaping Future Development
Leading firms within the virtual clinical trials market are prioritizing the creation of sophisticated solutions, like no-code digital trial platforms, to simplify intricate clinical processes. This type of no-code digital solution represents an accessible technology, empowering users to conceptualize, set up, and implement elements of clinical trials without requiring extensive technical knowledge, consequently cutting down on development periods, boosting precision, and elevating operational performance. As an illustration, in August 2024, Medable Inc., a US-based clinical trial technology company, introduced Medable Studio as an integral part of its digital trial platform. This particular innovation supplants conventional manual and labor-intensive configuration methods by enabling sponsors to construct, translate, verify, and initiate eCOA, eConsent, Televisit, and sensor-based workflows straight from an easy-to-use, click-based web interface. It provides immediate insight into study content, schedules, translations, and user journeys, concurrently allowing teams to readily tailor designs to fit protocols without depending on prolonged professional service engagements. Being integrated with Medable’s wider digital trial ecosystem, which encompasses remote data capture, patient engagement instruments, and consent workflows, it furnishes an optimized digital experience. This no-code platform speeds up study initiation, enhances operational oversight, and contributes to lessening trial durations and expenditures.
Virtual Clinical Trials Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the virtual clinical trials market report are ICON plc, Parexel International Pvt. Ltd., IQVIA Holdings Inc., Covance Research Products Inc., Pharmaceutical Research Associates Inc., Medidata Solution Inc., Oracle Corporation, Clario Tech Ltd., Medable Inc., Science 37 Holdings Inc., THREAD Research, Clinical Ink Inc., Veeva Systems Inc., Clinerion Ltd., CRF Health Group Limited, Crio Inc., Deep Lens Inc., Florence Healthcare Inc., goBalto Inc., Medrio Inc., Mint Medical Ltd., Mytrus Inc., OpenClinica LLC, PatientWing, RealTime-CTMS LLC, Reify Health, Sanguine Biosciences Inc., TriNetX Inc., VirTrial LLC
View The Full Virtual Clinical Trials Market Report:
Virtual Clinical Trials Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the virtual clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.